UpHealth downgraded by Lake Street with a new price target
$UPH
Retail: Computer Software & Peripheral Equipment
Technology
Lake Street downgraded UpHealth from Buy to Hold and set a new price target of $1.00 from $6.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/31/2022 | $6.00 → $1.00 | Buy → Hold | Lake Street |
| 10/25/2021 | $6.00 | Buy | Lake Street |
| 7/22/2021 | $12.00 | Outperform | Oppenheimer |
| 7/13/2021 | $13.00 | Outperform | Northland Capital |
Second Quarter Revenues Were $37.8 million and Gross Margin Expanded to 53% Year-to-Date Net Loss Attributable to UpHealth, Inc. Improved 9% to $27.2 million Year-to-Date Adjusted EBITDA Improved by $9.2 million to $11.8 million Closed Strategic Sale of Innovations Group, Inc. for $56.0 million Completed Repurchase of $10.3 Million of Convertible Debt Increasing Full Year 2023 Outlook DELRAY BEACH, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financi
DELRAY BEACH, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its second quarter ended June 30, 2023, after market close on Thursday, August 10, 2023. A conference call to discuss the results will follow at 5:00 p.m. Eastern Time on the same day. Those wishing to participate via the webcast should access the call through UpHealth's Investor Relations website at https://investors.uphealthinc.com. Those wishing to participate via the telep
First Quarter Revenues Increased 17% to $42.1 millionFirst Quarter Gross Margin Expanded to 54% First Quarter Net Loss Attributable to UpHealth, Inc. Decreased 54% to $8.1 millionFirst Quarter Adjusted EBITDA Improved by $7.9 million to $6.6 million Announced Strategic Sale of Innovations Group, Inc. for $56.0 million DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023. UpHealth Chief Executive Officer Sam Meckey
Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin BeckAnnounces the Promotion of Lisa Fluxman to President of TTC HealthcareReaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealthDELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replacing
Gainers SenesTech (NASDAQ:SNES) stock rose 42.0% to $2.67 during Monday's after-market session. TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 17.71% to $0.49. The market value of their outstanding shares is at $4.6 million. Heart Test Laboratories (NASDAQ:HSCS) stock rose 15.99% to $0.25. The company's market cap stands at $12.0 million. UpHealth (NYSE:UPH) shares rose 10.66% to $0.54. The company's market cap stands at $9.2 million. AcelRx Pharmaceuticals (NASDAQ:ACRX) shares moved upwards by 8.1% to $0.8. The market value of their outstanding shares is at $13.5 million. Sientra (NASDAQ:SIEN) stock rose 7.23% to $0.83. The company's market cap stands at $9.9 million. Losers Cent
DEFA14A - UpHealth, Inc. (0001770141) (Filer)
8-K - UpHealth, Inc. (0001770141) (Filer)
DEFM14A - UpHealth, Inc. (0001770141) (Filer)
SC 13D/A - UpHealth, Inc. (0001770141) (Subject)
SC 13D/A - UpHealth, Inc. (0001770141) (Subject)
SC 13D - UpHealth, Inc. (0001770141) (Subject)
Lake Street downgraded UpHealth from Buy to Hold and set a new price target of $1.00 from $6.00 previously
Lake Street initiated coverage of UpHealth with a rating of Buy and set a new price target of $6.00
Oppenheimer initiated coverage of UpHealth with a rating of Outperform and set a new price target of $12.00
Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac
Martin Beck Appointed CEO, Replacing Samuel Meckey Announces the Elimination of 20 Corporate Roles DELRAY BEACH, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the October 5, 2023 appointment by the Board of Directors of the Company of Martin Beck to serve as the Company's next Chief Executive Officer, replacing Samuel Meckey, effective October 6, 2023, and Mr. Beck being named as a member of the Board of Directors effective October 9, 2023. Mr. Beck has been UpHealth's Chie
Proposed New Independent Board Members Elected Stockholders Approved Reverse Split of the Company's Shares Stockholders Approve New Independent Auditor DELRAY BEACH, Fla., Dec. 05, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) announces the results of its first annual stockholder meeting, held December 5, 2022, virtually. All resolutions submitted for stockholder approval were adopted, including the following: Election of three Class I directors to hold office until the 2025 annual meeting and until their respective successors are elected and qualified.Approval of reverse stock split.Ratification of the appointment of BPM LLP as independent registered public accountin
Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac
DELRAY BEACH, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth") (OTC:UPHL), a global digital health company delivering a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services, today provided an update on the arbitration brought by UpHealth Holdings, Inc., a wholly-owned direct subsidiary of UpHealth ("Holdings"), against Glocal Healthcare Systems ("Glocal") and several of Glocal's officers and shareholders (together with Glocal, the "Respondents"). On March 18, 2024, the International Court of Arbitration of the International Chamber of Commerce (the "ICA") transmitted the Final Award to the parties. In the Final
DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("we," "our," "UpHealth," or the "Company") (NYSE:UPHL) today announced that it completed its previously announced sale of Cloudbreak Health, LLC ("Cloudbreak"), best known for its Martti™ translation offering, to a newly formed entity controlled by GTCR LLC for $180 million in gross cash proceeds on March 15, 2024. The $180 million in gross proceeds will be used to pay all closing expenses including any potential liability for taxes on the sale and paying down the Company's debt, including all of the Company's $115 million 2026 Notes and a substantial portion of its $57.2 million 2025 Notes. "This transaction is one m
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)
4 - UpHealth, Inc. (0001770141) (Issuer)